Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies has announced the availability of TECNIS Synergy Toric II OptiBlue PC-IOL (intraocular lens) for patients with astigmatism in India.
TECNIS Synergy Toric II IOL, is a continuous-range-of-vision lens engineered for rotational stability, which locks in visual performance and provides high-quality vision.
Cataracts are the leading cause of preventable blindness worldwide, impacting more than 100 million eyes, with more than 90% of people developing cataracts by the age of 65. Most people will develop cataracts at some point in their life, and modern cataract surgery is a safe and effective treatment that has a success rate of nearly 98%.
In India, nearly 73% of adults 60 years and older have cataracts and if left untreated, cause vision to deteriorate over time. Astigmatism reduces distance and near visual acuity, vision quality, and depth perception. All cataracts will eventually need to be surgically removed and replaced with an artificial lens, called an IOL.
Burzin Shahana, country manager at Johnson & Johnson Vision, Surgical Vision India, said,
